デフォルト表紙
市場調査レポート
商品コード
1247464

カテーテル安定化装置の世界市場-2023-2030

Global Catheter Stabilization Devices Market - 2023-2030

出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
カテーテル安定化装置の世界市場-2023-2030
出版日: 2023年03月28日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界のカテーテル安定化装置市場は、2022年には12億3,100万米ドルに達し、予測期間中(2023年~2030年)にCAGR 4.5%で成長すると予測されています。

カテーテル安定化装置は、カテーテルを所定の位置に固定し、ずれたり、誤って外れたりするのを防ぐように設計された医療機器です。カテーテルは細く柔軟な管で、輸液や投薬、身体機能の測定のために体内に挿入されます。カテーテル治療は一般的な医療処置であり、病院、診療所、在宅医療などさまざまな場面で使用されます。

市場力学

高まるカテーテル安定化デバイスのメリット

カテーテルは病院では当たり前のように使用されています。2021年にJournal of Vascular Accessに掲載された論文の通り、血管デバイスの最適な安定化はすべての挿入バンドルに含まれ、合併症のリスクを最小化するための重要なアプローチとしてsています。バスキュラーアクセスデバイスの適切な安定化は、デバイスの完全性を確保し、出口部位でのカテーテルの動きを最小限に抑え、カテーテルの脱落を防止する必要があります。市場の層は、ビジネスを拡大するために製品を提供しています。例えば、Eloquest Healthcare, Inc.は、皮下カテーテル固定装置SecurAcathを提供しています。この装置は、カテーテル挿入部位の皮膚のすぐ下に配置され、カテーテルシャフトに接続される小さなアンカー(セキュメントフット)を採用しています。

技術的な進歩

カテーテル安定化装置の技術的進歩は、市場にチャンスをもたらします。例えば、Delta Med S.p.A.が提供する縫合糸のない安定化装置は、カテーテルの適切な安定化を提供し、脱臼や合併症のリスクを低減するために不可欠です。装着が簡単で、カテーテルの先端が外れたり移動したりすることがなく、偶発的な刺し傷のリスクもなく、硬い部分がないのでより快適です。また、ストレートPIVカテーテルを固定する場合、3M Tegaderm I.V. Advanced Securement Dressing 1683とテープストリップは、主要な標準フィルムドレッシングとテープストリップに比べて48時間後に3倍の引っ張り力に耐えることができました。

カテーテル安定化器具の欠点

皮膚接着性の縫合糸なしデバイス(ドレッシングと分離しているか、透明な膜に組み込まれている)は、十分で安全ですが、いくつかの問題があります:毎週交換しなければならない、脱落を抑制するのに100%有効ではない、出口部位の適切な消毒を妨げる、出口部位でカテーテルの「出入り」微動ができる、MARSI(医療接着関連皮膚障害)を引き起こす可能性がある、。

目次

第1章 調査手法とスコープ

  • 調査手法
  • 調査目的および調査範囲について

第2章 定義と概要

第3章 エグゼクティブサマリー

  • 製品別スニペット
  • アプリケーション別スニペット
  • エンドユーザー別スニペット
  • 地域別スニペット

第4章 ダイナミックス

  • インパクトのあるファクター
    • 促進要因
      • 技術的な進歩
      • 慢性疾患の普及率向上
    • 抑制要因
      • 代替品の有無
    • 機会
    • 影響度分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格アナリシス
  • レギュラトリー・アナリシス

第6章 COVID-19の分析

  • COVID-19の解析について
    • COVID-19シナリオ前
    • 現在のCOVID-19シナリオ
    • ポストCOVID-19またはフューチャーシナリオ
  • COVIDの中での価格ダイナミクス-19
  • 需給スペクトル
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • 結論

第7章 製品別

  • 末梢用カテーテル固定装置
    • フォーリーカテーテル固定用器具
    • 経鼻胃管固定装置
    • 気管内チューブ固定装置
    • 心室腹膜固定装置
    • 連続式神経ブロックカテーテル固定用具
    • ミッドライン固定装置
  • 中心静脈カテーテル固定用器具
    • ポータル確保装置
    • PICC固定装置
    • 鎖骨下固定装置
    • 大腿骨固定装置
    • 頸動脈確保装置
  • 動脈カテーテル固定用器具
  • 胸腔ドレナージチューブ固定装置
  • 腹腔ドレナージチューブ固定用器具
  • 硬膜外固定装置
  • 全周囲固定装置

第8章 アプリケーション別

  • 心血管系処置
  • 呼吸器の手順
  • 胃と口腔咽頭の処置
  • 一般外科
  • 泌尿器科手術
  • 放射線学
  • その他の用途

第9章 エンドユーザー別

  • 病院
  • 外来診療所(Ambulatory Surgery Clinic
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢について

  • 競合シナリオ
  • 市況分析・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Omron Corporation
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な展開
  • Koninklijke Philips N.V
  • 3M
  • Allied Healthcare Products, Inc
  • Becton, Dickinson and Compan
  • Agilent Technologies
  • Medline Industries, Inc.
  • Briggs Healthcare
  • Cathetrix
  • GF Health Products, Inc

第13章 付録

目次
Product Code: MD1470

Market Overview

The global catheter stabilization devices market reached US$ 1,231 million in 2022 and is projected to witness lucrative growth by reaching up to US$ XX million by 2030. The market is growing at a CAGR of 4.5% during the forecast period (2023-2030).

Catheter stabilization devices are medical devices that are designed to secure a catheter in place, preventing it from shifting or being accidentally dislodged. Catheters are thin, flexible tubes that are inserted into the body to deliver fluids, and medications, or to measure bodily functions. Catheterization is a common medical procedure that is used in a variety of settings, including hospitals, clinics, and home care.

Market Dynamics

The growing benefits of catheter stabilization devices

Catheters are commonplace in hospital settings. As per the article published in the Journal of Vascular Access in 2021, the optimal stabilization of the vascular device is part of all insertion bundles and is s as an important approach to minimize the risk of complications. Adequate stabilization of a vascular access device must ensure the integrity of the device, minimize the motion of the catheter at the exit site, and prevent the dislodgment of the catheter. The market layers are offering the products to expand their business. For instance, Eloquest Healthcare, Inc. offers SecurAcath a subcutaneous catheter securement system. The device employs a small anchor (securement feet) positioned just beneath the skin at the catheter insertion site and connected to the catheter shaft.

Technological advancements

The technological advances in catheter stabilization devices open opportunities in the market. For instance, sutureless stabilization devices offered by Delta Med S.p.A. which is provided proper stabilization of the catheter are essential to reduce the risk of dislocations and complications. They are easy to apply, they avoid dislocation and migration of the catheter tip, they eliminate the risk of accidental puncture wounds, and they are more comfortable as they have no rigid parts. Also When securing a straight PIV catheter, 3M Tegaderm I.V. Advanced Securement Dressing 1683 plus tape strips withstood three times the pull force after 48 hours of the leading standard film dressing plus tape strip.

The drawbacks of catheter stabilization devices

Skin-adhesive sutureless devices (either separate from the dressing or integrated into the transparent membrane) are sufficient and secure but may have some impediments: they must be replaced weekly; they are not 100% effective in controlling dislodgment; they interfere with adequate disinfection of the exit site; they allow "in and out" micromovements of the catheter at the exit-site, also they might generate MARSI (Medical Adhesive-Related Skin Injury).

Segment Analysis

The global catheter stabilization devices market is segmented based on product, application, end-user, and region.

Owing to their versatility and cost-effectiveness, the peripheral catheter securement devices

Peripheral catheter securement devices are a type of catheter stabilization device that are used specifically to secure peripheral intravenous catheters (PIVCs) in place. PIVCs are short, thin tubes that are inserted into a peripheral vein, typically in the arm or hand, to deliver medications, fluids, or nutrients. PIVCs are commonly used in hospitals, clinics, and other healthcare settings. Peripheral catheter securement devices are designed to hold the PIVC securely in place, preventing it from becoming dislodged or moving around. These devices can be adhesive-based, using tape or similar materials to secure the catheter to the skin, or they can be mechanical-based, using clips or other devices to hold the catheter in place.

Geographical Penetration

The strong presence of major players and technological advancements

The growing demand in developing countries, especially in Europe, creates opportunities for manufacturers to expand their operations in these regions. The increasing chronic disease in the Europe region drives the market. For instance, according to European Chronic Disease Alliance, chronic disease is the main cause of mortality in Europe, representing 77% of the total disease burden and 86% of all deaths. Also, active players are offering catheter stabilization devices in the market. For instance, Bunzl Healthcare (London) offers The Statlcok PICC device, which eliminates the need to secure a catheter with a suture. It secures the catheter in place. and is compatible for use with a wide variety of PICC catheters. It is faster and easier to apply than suture and permits visibility of the insertion site. The foam anchor pad is made from breathable latex-free tricot fabric that delivers added catheter security and patient comfort. The device has sliding pads.

Competitive Landscape

The major global players include Omron Corporation, Koninklijke Philips N.V., 3M, Allied Healthcare Products, Inc., Becton, Dickinson and Company, Agilent Technologies, Medline Industries, Inc., Briggs Healthcare, Cathetrix, GF Health Products, Inc.

COVID-19 Impact Analysis

By Product

  • Peripheral Catheter Securement Devices
    • Foley Catheter Securement Devices
    • Nasogastric Tube Securement Devices
    • Endotracheal Tube Securement Devices
    • Ventriculoperitoneal Securement Devices
    • Continuous Nerve Block Catheter Securement Devices
    • Midlines Securement Devices
  • Central Venous Catheter Securement Devices
    • Portal Securement Devices
    • PICC Securement Devices
    • Subclavian Securement Devices
    • Femoral Securement Devices
    • Jugular Securement Devices
  • Arterial Catheter Securement Devices
  • Chest Drainage Tube Securement Devices
  • Abdominal Drainage Tube Securement Devices
  • Epidural Securement Devices
  • All-Site Securement Devices

By Application

  • Cardiovascular Procedures
  • Respiratory Procedures
  • Gastric and Oropharyngeal Procedures
  • General Surgery
  • Urological Procedures
  • Radiology
  • Other Applications

By End-user

  • Hospitals
  • Ambulatory Surgery Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In December 2022, CATHETRIX, an innovative developer of urinary (Foley) smart catheter fixation devices, announced that it will commercially launch its catheter stabilizer for the prevention of urinary tract infections (UTIs) and accidental Foley catheter extractions at the Arab Health 2023, which will take place January 30-February 2, 2023, in Dubai, UAE.
  • In September 2022, B. Braun Medical Inc. declared that it has acquired the Clik-Fix catheter securement device product portfolio from Starboard Medical, Inc., adding to the company's portfolio of peripheral intravenous (IV) therapy devices.

Why Purchase the Report?

  • To visualize the global Catheter Stabilization Devices- market segmentation based on product, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Catheter Stabilization Devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global Catheter Stabilization Devices market report would provide approximately 61 tables, 64 figures and 195+ Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-user
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological Advancements
      • 4.1.1.2. Increasing Prevalence Of Chronic Diseases
      • 4.1.1.3. XX
    • 4.1.2. Restraints
      • 4.1.2.1. Availability Of Alternative Products
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. XX
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Peripheral Catheter Securement Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Foley Catheter Securement Devices
    • 7.2.4. Nasogastric Tube Securement Devices
    • 7.2.5. Endotracheal Tube Securement Devices
    • 7.2.6. Ventriculoperitoneal Securement Devices
    • 7.2.7. Continuous Nerve Block Catheter Securement Devices
    • 7.2.8. Midlines Securement Devices
  • 7.3. Central Venous Catheter Securement Devices
    • 7.3.1. Portal Securement Devices
    • 7.3.2. PICC Securement Devices
    • 7.3.3. Subclavian Securement Devices
    • 7.3.4. Femoral Securement Devices
    • 7.3.5. Jugular Securement Devices
  • 7.4. Arterial Catheter Securement Devices
  • 7.5. Chest Drainage Tube Securement Devices
  • 7.6. Abdominal Drainage Tube Securement Devices
  • 7.7. Epidural Securement Devices
  • 7.8. All-Site Securement Devices

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiovascular Procedures*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Respiratory Procedures
  • 8.4. Gastric and Oropharyngeal Procedures
  • 8.5. General Surgery
  • 8.6. Urological Procedures
  • 8.7. Radiology
  • 8.8. Other Applications

9. By End-user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 9.1.2. Market Attractiveness Index, By End-user
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgery Clinics
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Omron Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Koninklijke Philips N.V
  • 12.3. 3M
  • 12.4. Allied Healthcare Products, Inc
  • 12.5. Becton, Dickinson and Compan
  • 12.6. Agilent Technologies
  • 12.7. Medline Industries, Inc.
  • 12.8. Briggs Healthcare
  • 12.9. Cathetrix
  • 12.10. GF Health Products, Inc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services